Technical Analysis for CTMX - CytomX Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 4.19 | 2.95% | 0.12 |
CTMX closed up 2.95 percent on Wednesday, May 8, 2024, on 5.61 times normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Hammer Candlestick | Bullish | 0.00% | |
| 180 Bullish Setup | Bullish Swing Setup | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Volume Surge | Other | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Earnings Movers | Other | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Upper Bollinger Band Walk | Strength | 2.95% | |
| Earnings Movers | Other | 2.95% | |
| Wide Bands | Range Expansion | 2.95% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 17 hours ago |
| Down 5% | about 22 hours ago |
| Down 3% | about 23 hours ago |
| Fell Below Previous Day's Low | about 23 hours ago |
| Down 2 % | about 23 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2024
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology, such as PD-L1, as well as novel targets, comprising CD-166. In addition it has strategic collaborations with Bristol-Myers Squibb Company, Pfizer Inc., and ImmunoGen, Inc. to develop selected Probody therapeutics. The company was founded in 2008 and is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Compugen Monoclonal Antibody Therapy Immunogen Oncology Focused Biopharmaceutical
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Compugen Monoclonal Antibody Therapy Immunogen Oncology Focused Biopharmaceutical
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.85 |
| 52 Week Low | 1.04 |
| Average Volume | 6,466,539 |
| 200-Day Moving Average | 1.68 |
| 50-Day Moving Average | 2.39 |
| 20-Day Moving Average | 2.57 |
| 10-Day Moving Average | 3.31 |
| Average True Range | 0.47 |
| RSI (14) | 70.06 |
| ADX | 45.04 |
| +DI | 49.68 |
| -DI | 14.31 |
| Chandelier Exit (Long, 3 ATRs) | 4.43 |
| Chandelier Exit (Short, 3 ATRs) | 3.00 |
| Upper Bollinger Bands | 5.08 |
| Lower Bollinger Band | 0.06 |
| Percent B (%b) | 0.82 |
| BandWidth | 195.16 |
| MACD Line | 0.60 |
| MACD Signal Line | 0.33 |
| MACD Histogram | 0.2678 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.81 | ||||
| Resistance 3 (R3) | 4.75 | 4.48 | 4.71 | ||
| Resistance 2 (R2) | 4.48 | 4.32 | 4.51 | 4.67 | |
| Resistance 1 (R1) | 4.33 | 4.22 | 4.41 | 4.40 | 4.64 |
| Pivot Point | 4.06 | 4.06 | 4.10 | 4.09 | 4.06 |
| Support 1 (S1) | 3.92 | 3.90 | 3.99 | 3.98 | 3.74 |
| Support 2 (S2) | 3.65 | 3.81 | 3.68 | 3.71 | |
| Support 3 (S3) | 3.50 | 3.65 | 3.67 | ||
| Support 4 (S4) | 3.57 |
